Shenzhen Kaifa Technology
920029
Shanghai Yongli Belting
300230
Guomai Culture & Media
301052
4
WuHan Hvsen Biotechnology
300871
5
CHANGFU CO.,LTD
871396
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | |||||||
Cash flow from continuing operating activities | 44.75%-16.15M | 45.47%-2.78M | 47.70%-29.23M | 77.37%-5.11M | -54.75%-55.88M | -22.56M | -36.11M |
Net income from continuing operations | -13.29%-65.39M | 18.40%-6.26M | -11.64%-57.72M | 46.26%-7.67M | -34.28%-51.7M | ---14.27M | ---38.5M |
Operating gains losses | -2,711.44%-11.56M | -95,000.00%-951K | 81.01%-411K | -100.27%-1K | 73.85%-2.16M | --374K | ---8.27M |
Depreciation and amortization | -99.91%2K | --0 | -43.65%2.14M | --0 | -11.85%3.79M | --693K | --4.3M |
Other non cash items | 1,117.74%47.15M | -83.65%565K | 14,240.74%3.87M | --3.46M | -99.65%27K | ---- | --7.79M |
Change In working capital | -750.72%-4.52M | 185.29%835K | 109.92%694K | 89.87%-979K | -87.76%-6.99M | ---9.67M | ---3.73M |
-Change in receivables | ---- | ---- | ---- | ---- | 200.00%1.8M | --0 | ---1.8M |
-Change in inventory | -548.94%-1.53M | 620.85%1.22M | ---235K | ---235K | ---- | ---- | ---- |
-Change in prepaid assets | 162.59%184K | -1,714.71%-549K | -155.89%-294K | 104.26%34K | 141.25%526K | ---798K | ---1.28M |
-Change in payables and accrued expense | -1,562.64%-2.55M | 117.74%329K | 109.48%174K | -2,373.33%-1.86M | -262.53%-1.84M | ---75K | --1.13M |
-Change in other current assets | -114.87%-106K | 127.27%12K | 107.92%713K | 99.52%-44K | -2,433.42%-9.01M | ---9.26M | --386K |
-Change in other current liabilities | -255.95%-524K | -116.15%-181K | -77.94%336K | 142.12%1.12M | 230.62%1.52M | --463K | ---1.17M |
-Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---1M |
Cash from discontinued investing activities | |||||||
Operating cash flow | 44.75%-16.15M | 45.47%-2.78M | 47.70%-29.23M | 77.37%-5.11M | -54.75%-55.88M | ---22.56M | ---36.11M |
Investing cash flow | |||||||
Cash flow from continuing investing activities | 96.61%-23K | 0 | 91.62%-678K | 99.35%-9K | -194.96%-8.09M | -1.39M | 8.52M |
Net PPE purchase and sale | 96.61%-23K | --0 | 91.62%-678K | 99.35%-9K | 33.69%-8.09M | ---1.39M | ---12.2M |
Net investment purchase and sale | ---- | ---- | ---- | ---- | --0 | ---- | --20.71M |
Cash from discontinued investing activities | |||||||
Investing cash flow | 96.61%-23K | --0 | 91.62%-678K | 99.35%-9K | -194.96%-8.09M | ---1.39M | --8.52M |
Financing cash flow | |||||||
Cash flow from continuing financing activities | 238.86%18.81M | -102.50%-139K | -81.39%5.55M | -81.32%5.55M | -57.03%29.83M | 29.72M | 69.41M |
Net issuance payments of debt | 175.36%19.19M | -99.99%1K | -74.06%6.97M | -76.55%6.97M | 1,301.74%26.87M | --29.72M | ---2.24M |
Net common stock issuance | --360K | ---- | --0 | ---- | ---- | ---- | ---- |
Net preferred stock issuance | ---- | ---- | ---- | ---- | -96.03%2.8M | --0 | --70.53M |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | -86.05%156K | --1K | --1.12M |
Net other financing activities | 47.81%-740K | ---500K | ---1.42M | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | |||||||
Financing cash flow | 238.86%18.81M | -102.50%-139K | -81.39%5.55M | -81.32%5.55M | -57.03%29.83M | --29.72M | --69.41M |
Net cash flow | |||||||
Beginning cash position | -96.30%934K | 1,448.81%6.51M | -57.43%25.27M | -97.85%420K | 238.17%59.37M | --19.5M | --17.56M |
Current changes in cash | 110.84%2.64M | -768.88%-2.92M | 28.67%-24.35M | -92.43%437K | -181.64%-34.14M | --5.77M | --41.81M |
Effect of exchange rate changes | -616.67%-62K | -190.91%-70K | -72.09%12K | 3,950.00%77K | --43K | ---2K | --0 |
End cash Position | 276.02%3.51M | 276.02%3.51M | -96.30%934K | -96.30%934K | -57.43%25.27M | --25.27M | --59.37M |
Free cash flow | 46.43%-16.17M | 45.56%-2.78M | 52.81%-30.19M | 78.64%-5.11M | -31.83%-63.97M | ---23.95M | ---48.52M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |